Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zifivax Booster After BBIBP-CorV Vaccination in Adults
NCT05205083Phase 2Unknown
- Sponsor
- Zhifei Biological
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ZF2001 in coronavirus disease 2019 (COVID-19), sponsored by Zhifei Biological. Status: unknown.
02
Drugs
ZF2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05205083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05205083.